S&P 500   4,088.85 (+2.02%)
DOW   32,654.59 (+1.34%)
QQQ   306.17 (+2.59%)
AAPL   149.24 (+2.54%)
MSFT   266.82 (+2.03%)
FB   202.62 (+1.29%)
GOOGL   2,329.46 (+1.77%)
AMZN   2,307.37 (+4.11%)
TSLA   761.61 (+5.14%)
NVDA   181.77 (+5.29%)
BABA   91.99 (+6.37%)
NIO   16.63 (+14.30%)
AMD   102.47 (+8.73%)
CGC   5.89 (+2.79%)
MU   74.48 (+5.69%)
T   20.57 (+1.43%)
GE   76.40 (+2.37%)
F   13.53 (+3.68%)
DIS   108.64 (+3.29%)
AMC   12.90 (+10.16%)
PFE   51.34 (+1.32%)
PYPL   79.75 (+2.70%)
NFLX   190.56 (+2.17%)
S&P 500   4,088.85 (+2.02%)
DOW   32,654.59 (+1.34%)
QQQ   306.17 (+2.59%)
AAPL   149.24 (+2.54%)
MSFT   266.82 (+2.03%)
FB   202.62 (+1.29%)
GOOGL   2,329.46 (+1.77%)
AMZN   2,307.37 (+4.11%)
TSLA   761.61 (+5.14%)
NVDA   181.77 (+5.29%)
BABA   91.99 (+6.37%)
NIO   16.63 (+14.30%)
AMD   102.47 (+8.73%)
CGC   5.89 (+2.79%)
MU   74.48 (+5.69%)
T   20.57 (+1.43%)
GE   76.40 (+2.37%)
F   13.53 (+3.68%)
DIS   108.64 (+3.29%)
AMC   12.90 (+10.16%)
PFE   51.34 (+1.32%)
PYPL   79.75 (+2.70%)
NFLX   190.56 (+2.17%)
S&P 500   4,088.85 (+2.02%)
DOW   32,654.59 (+1.34%)
QQQ   306.17 (+2.59%)
AAPL   149.24 (+2.54%)
MSFT   266.82 (+2.03%)
FB   202.62 (+1.29%)
GOOGL   2,329.46 (+1.77%)
AMZN   2,307.37 (+4.11%)
TSLA   761.61 (+5.14%)
NVDA   181.77 (+5.29%)
BABA   91.99 (+6.37%)
NIO   16.63 (+14.30%)
AMD   102.47 (+8.73%)
CGC   5.89 (+2.79%)
MU   74.48 (+5.69%)
T   20.57 (+1.43%)
GE   76.40 (+2.37%)
F   13.53 (+3.68%)
DIS   108.64 (+3.29%)
AMC   12.90 (+10.16%)
PFE   51.34 (+1.32%)
PYPL   79.75 (+2.70%)
NFLX   190.56 (+2.17%)
S&P 500   4,088.85 (+2.02%)
DOW   32,654.59 (+1.34%)
QQQ   306.17 (+2.59%)
AAPL   149.24 (+2.54%)
MSFT   266.82 (+2.03%)
FB   202.62 (+1.29%)
GOOGL   2,329.46 (+1.77%)
AMZN   2,307.37 (+4.11%)
TSLA   761.61 (+5.14%)
NVDA   181.77 (+5.29%)
BABA   91.99 (+6.37%)
NIO   16.63 (+14.30%)
AMD   102.47 (+8.73%)
CGC   5.89 (+2.79%)
MU   74.48 (+5.69%)
T   20.57 (+1.43%)
GE   76.40 (+2.37%)
F   13.53 (+3.68%)
DIS   108.64 (+3.29%)
AMC   12.90 (+10.16%)
PFE   51.34 (+1.32%)
PYPL   79.75 (+2.70%)
NFLX   190.56 (+2.17%)
NYSEAMERICAN:NBY

NovaBay Pharmaceuticals SEC Filings & 10K Form

$0.20
+0.01 (+5.26%)
(As of 05/17/2022 04:00 PM ET)
Add
Compare
Today's Range
$0.19
$0.22
50-Day Range
N/A
52-Week Range
$0.17
$0.88
Volume
632,771 shs
Average Volume
456,834 shs
Market Capitalization
$10.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
3.47

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) SEC Filings

DateFilerForm TypeView
05/13/2022
7:33 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
WU MIJIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2022
7:33 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Sit Swan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2022
7:32 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Zheng Yongxiang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2022
7:32 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Zheng Yenyou (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2022
7:31 PM
Garlikov Julie (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2022
7:31 PM
Freiman Paul E. (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2022
3:46 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/21/2021
3:30 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2021
4:12 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2021
3:46 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Sit Swan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
3:46 PM
Li Xinzhou (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
3:46 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Zheng Yenyou (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2021
3:45 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2021
4:03 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2021
5:00 PM
Jones Andrew D. (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
3:11 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/07/2021
11:15 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form EFFECT
04/07/2021
4:23 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
04/07/2021
4:16 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEF 14A
04/02/2021
4:18 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form S-3/A
03/26/2021
3:30 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form PRE 14A
03/26/2021
6:30 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/08/2021
7:22 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2021
3:31 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/18/2020
3:30 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2020
6:30 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2020
7:00 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2020
11:15 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form EFFECT
08/24/2020
4:04 PM
Fu Jian Ping (Filed by)
NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
Form SC 13D/A
08/24/2020
3:49 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Xu Wang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
3:49 PM
Jones Andrew D. (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
3:49 PM
Hall Justin (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
3:47 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Wang Xiaopei (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
3:31 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2020
3:31 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/19/2020
3:24 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
WU MIJIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2020
5:04 PM
Fu Jian Ping (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2020
8:07 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 424B3
07/21/2020
8:00 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2020
7:18 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2020
7:07 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 424B5
05/29/2020
4:04 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
WU MIJIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
4:03 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Zheng Yenyou (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
4:02 PM
Li Xinzhou (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
4:02 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Wang Xiaopei (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
4:01 PM
Freiman Paul E. (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
4:00 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Sit Swan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
3:30 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2020
11:15 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form EFFECT
05/22/2020
7:23 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
05/15/2020
4:15 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/15/2020
3:11 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2020
6:29 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2020
3:30 PM
Jones Andrew D. (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/05/2020
6:03 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2020
7:22 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
04/27/2020
3:56 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2020
6:04 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2020
3:41 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEFA14A
04/15/2020
3:32 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEF 14A
03/26/2020
3:12 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2020
3:30 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
1:27 PM
ARMISTICE CAPITAL, LLC (Filed by)
NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
Form SC 13G/A
02/10/2020
11:15 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form EFFECT
02/07/2020
3:49 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/06/2020
8:22 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
4:50 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Sit Swan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2020
2:05 PM
Empery Asset Management, LP (Filed by)
NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
Form SC 13G/A
12/18/2019
8:58 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Wang Xiaopei (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/07/2019
3:11 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
11:15 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form EFFECT
10/30/2019
3:31 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Zavodnick Todd Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
3:30 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Raleigh Jason Philip (Reporting)
Form 4/A
10/28/2019
3:29 PM
Hall Justin (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4/A
10/28/2019
3:28 PM
Li Xinzhou (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
3:27 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
WU MIJIA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
3:25 PM
Maderis Gail J (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
3:25 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
SIECZKAREK MARK M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
3:24 PM
Freiman Paul E. (Reporting)
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2019
3:32 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/10/2019
3:30 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2019
7:56 PM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
Zheng Yenyou (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/16/2019
3:30 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2019
7:30 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form DEF 14A
09/12/2019
11:15 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form EFFECT
09/04/2019
3:32 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/30/2019
3:31 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form PRE 14A
08/26/2019
1:11 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
08/26/2019
1:06 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form D
Notice of Exempt Offering of Securities 
08/19/2019
4:13 PM
ARMISTICE CAPITAL, LLC (Filed by)
NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
Form SC 13G
08/15/2019
12:28 PM
Empery Asset Management, LP (Filed by)
NovaBay Pharmaceuticals (Subject)
NovaBay Pharmaceuticals, Inc. (Subject)
Form SC 13G
08/09/2019
4:02 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 424B5
08/09/2019
8:02 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
7:00 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
5:53 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
7:18 AM
NovaBay Pharmaceuticals (Issuer)
NovaBay Pharmaceuticals, Inc. (Issuer)
SIECZKAREK MARK M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2019
11:15 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form EFFECT
07/29/2019
7:30 AM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2019
4:01 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/25/2019
3:30 PM
NovaBay Pharmaceuticals (Filer)
NovaBay Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 5/17/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.